KTKristin A. Tissera

Kristin A. Tissera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kristin A. Tissera has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review

    by Christian L. Bailey-Burke, Kristin A. Tissera, Lauren Baughman, Samantha A. Polly, Meenal Kheterpal


  • Open Access

    A Retrospective Comparison of Narrowband-UVB Phototherapy in Pediatric Versus Adult Vitiligo

    by Kristin A. Tissera, Elena B. Hawryluk, Anna Cristina Garza-Mayers

    Background/Objectives: Vitiligo is an autoimmune condition causing melanocyte destruction and skin depigmentation. First-line treatments for vitiligo include topical medications and phototherapy; however, access and utilization of these treatments vary, particularly in pediatric patients. This study evaluates nbUVB use in pediatric versus adult vitiligo patients to better understand utilization in the pediatric population. Methods: A retrospective chart review study was conducted, collecting demographics and treatment characteristics for 102 adults and 19 children with vitiligo treated with nbUVB phototherapy at one institution. Statistical analysis included comparisons for categorical variables made using Chi-squared test or Fisher’s exact test, as appropriate, and using a non-parametric Mann–Whitney U test for continuous variables. Results: On average, adults underwent nbUVB for 23.8 months (range 0.5–418, median 9), while children had an average duration of 14.8 months (range 2–60, median 8). The average number of nbUVB sessions for adults was 83.8, whereas children had an average of 33.5 sessions. Overall, 59.6% of adults and 60.0% of children experienced repigmentation with nbUVB. Conclusions: Retrospective analysis indicated that the duration and frequency of nbUVB sessions varied widely among both adults and children. While the average duration of treatment was comparable between the groups, children underwent fewer sessions on average. This may reflect differences in physician recommendation, scheduling constraints, or treatment adherence. Despite this variability, most pediatric patients exhibited repigmentation, supporting nbUVB efficacy. Our results suggest nbUVB is underutilized in pediatric vitiligo. Addressing obstacles to access is crucial for improving treatment outcomes and quality of life.

  • Survey of Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo

    by Kristin A. Tissera, Elena B. Hawryluk, John E. Harris, Anna Cristina Garza‐Mayers

    This study sought to evaluate narrowband UVB phototherapy in pediatric vitiligo through an online patient and caregiver survey to better understand patient experiences and barriers to care in this population. In a survey of 111 respondents, 51.4% were offered nbUVB and 45.1% utilized nbUVB for treatment of vitiligo before age 18 years. The primary reasons for not pursuing nbUVB included it not being offered (36.1%), difficulty attending appointments (11.5%), and satisfaction with the current skin condition (11.5%). Our results suggest nbUVB may be underutilized in pediatric vitiligo; addressing obstacles to access is crucial for improving treatment outcomes and quality of life.


  • Investigation of Hearing Loss in Pediatric Vitiligo

    by Kristin A. Tissera, Amy Buros‐Stein, Camile Delva, Omkar Mayur, Elena B. Hawryluk, John E. Harris, Anna Cristina Garza‐Mayers

    Prior studies have investigated the association between vitiligo and sensorineural hearing loss in adults; based on this potential association, we aimed to investigate the association of vitiligo with hearing loss in children. This was conducted as an IRB‐approved multi‐center retrospective analysis of pure tone audiometry and otoacoustic emission testing of 158 pediatric vitiligo patients compared to 316 age‐ and sex‐matched healthy subjects at three institutions between 2000 and 2023. Our results demonstrate no significant increased incidence of hearing deficit in pediatric vitiligo patients, though both vitiligo and control populations demonstrated increased incidence of hearing loss. Further studies are required to determine whether pediatric vitiligo patients may benefit from early and/or regular screening examination and intervention, as hearing is critical for speech, language, and social development.


  • No Association of Pediatric Vitiligo With Visual Acuity Deficits

    by Kristin A. Tissera, Amy Buros‐Stein, Camile A. Delva, Omkar Mayur, Elena B. Hawryluk, John E. Harris, Anna Cristina Garza‐Mayers

    Vitiligo is characterized by the autoimmune destruction of melanocytes, which most visibly affect skin pigmentation, but are also present in the choroid and retinal pigmented epithelium of the eye raising the possibility of underappreciated vision loss in affected populations. To inform whether this vulnerable population should be more rigorously screened and offered early intervention, we performed a multi‐center retrospective analysis of optotype recognition of 248 pediatric vitiligo patients compared with 496 age‐ and sex‐matched healthy subjects between 2000 and 2023; we found a significant difference in the risk of visual acuity deficits in patients as compared with healthy controls ( p = 0.0476), although this association was lost when controlling for family history and genetic diagnoses associated with visual acuity deficits or vision loss. These results extend prior studies in adult populations and are consistent with current guidelines that do not recommend routine vision screening the pediatric vitiligo population, although further studies are warranted to determine if there are more subtle changes in vision and eye function.

  • ‘I need to understand… so we can decide together’: Difficult conversations about alopecia areata

    by Kristin A. Tissera, Kristina Gorbatenko‐Roth, Neil S. Prose, Kirsten Johnson

    The management of alopecia areata (AA) in pediatric patients poses unique challenges, particularly regarding treatment discussions and decision making involving both patients and their families. This commentary presents findings from unpublished research on treatment‐discontinuation discussions between AA patients and their treating providers, shedding light on the hopes, expectations, and disappointments of individuals with severe AA. The study explored patient and guardian satisfaction with these discussions, emphasizing the importance of addressing psychosocial concerns, facilitating contact with support groups, and demonstrating empathy. The role of dermatologists in conversations about treatment, prognosis, and quality of life is examined, emphasizing the need for honesty, empathy, and realistic expectations. The authors propose a patient‐centered approach to initiating and guiding discussions, focusing on understanding the impact of AA on patients and their families and collaboratively deciding on treatment options. The mantra: ‘I need to understand how this is affecting all of you, so we can decide together what to do next’ is central to this proposed approach. Special considerations for different scenarios are discussed, highlighting the importance of individualized care and effective communication. Overall, the commentary emphasizes the significance of actively listening, acknowledging emotions, and prioritizing patient and family goals to optimize care for pediatric AA patients.


  • Open Access

    Updates in the Management of Congenital Melanocytic Nevi

    by Mia A. Mologousis, Serena Yun-Chen Tsai, Kristin A. Tissera, Yakir S. Levin, Elena B. Hawryluk

    Congenital melanocytic nevi (CMN) carry an increased risk of melanoma and may be disfiguring, and consensus regarding treatment recommendations is lacking. While clinical monitoring is the standard of care, many caregivers are interested in its removal to prevent psychosocial burden or to decrease risk. Although melanoma can occur regardless of CMN removal, there are a variety of treatments that may offer improved cosmesis or local symptom control, including surgical excision, laser therapy, and other superficially destructive techniques. Regardless of the selected management, these patients are monitored for ongoing melanoma risk. An extensive discussion with families regarding the risks and benefits of observation versus active intervention is essential. To facilitate these discussions, we herein summarize current CMN management strategies and considerations.


  • Retrospective Review of Midpoint Vestibular Aqueduct Size in the 45° Oblique (Pöschl) Plane and Correlation with Hearing Loss in Patients with Enlarged Vestibular Aqueduct

    by K. Bouhadjer, K. Tissera, C.W. Farris, A.F Juliano, M.E. Cunnane, H.D. Curtin, L.A. Mankarious, K.L. Reinshagen

    Objective To compare the prevalence of sexually transmitted infections (STIs) (including HIV) and of high-risk sexual behaviour in the following three groups: primary infertile relationships, secondary infertile relationships and fertile relationships. Primary infertility is here defined as never having conceived before, secondary infertility as infertility subsequent to having conceived at least once. Design Unmatched case–control study. Methods Sexually active infertile women aged 21–45 years presenting at an infertility clinic of the Kigali Teaching Hospital, Rwanda and their male partners were invited to participate. Fertile controls who had recently delivered were recruited from the community. In a face-to-face interview, participants were asked about sociodemographic characteristics and their sexual behaviours, and tested for HIV and STIs. Results Between November 2007 and May 2009, 312 women and 254 partners in infertile relationships and 312 women and 189 partners in fertile relationships were enrolled. Involvement in a secondary infertile relationship was associated with HIV infection after adjusting for sociodemographic covariates for women (adjusted OR (AOR)=4.03, 95% CI 2.4 to 6.7) and for men (AOR=3.3, 95% CI 1.8 to 6.4). Involvement in a primary infertile relationship, however, was not. Secondary infertile women were more likely to have engaged in risky sexual behaviour during their lifetime compared with primary infertile and fertile women. Men in primary and secondary infertile relationships more often reported multiple partners in the past year (AOR=5.4, 95% CI 2.2 to 12.7; AOR=7.1, 95% CI 3.2 to 15.8, respectively). Conclusions Increased HIV prevalence and risky sexual behaviour among infertile couples is driven by secondary infertility. Infertile couples, and especially those with secondary infertility, should be targeted for HIV prevention programmes and their fertility problems should be addressed.


  • Cognitive and Behavioral Functioning in Hearing‐Impaired Children with and without Language Delay

    by Alisha Williams, Margaret Pulsifer, Kristin Tissera, Leila A. Mankarious

    Poor language development in patients with sensorineural hearing loss (SNHL) may be related to an auditory deficit and/or other neurologic condition that influences the ability to communicate. A retrospective chart review of children (mean age = 4.0 years) with congenital, bilateral SNHL was performed to assess for linguistic and nonlinguistic neurodevelopmental differences between those who were language‐impaired (LI) versus non–language‐impaired (NLI). Language, neurodevelopmental functioning, and behavior were assessed. Twenty‐two patients were identified: 12 were LI and 10 were NLI. Average pure‐tone thresholds and nonverbal intelligence were not different between the language groups, but the LI group demonstrated significantly lower median overall adaptive skills, personal living skills, and motor skills. Behavioral dysregulation was significantly higher in the LI versus NLI group (58% vs 10%; P =. 031), although the median neurodevelopmental scores did not differ significantly. These findings introduce the possibility that nonlinguistic processing deficit(s) may be confounding the ability to develop language.


  • Leveraging Existing Tools in Electronic Health Record Systems to Automate Clinical Registry Compilation

    by Alisha Williams, William Goedicke, Kristin A. Tissera, Leila A. Mankarious

    Clinical registries have proven beneficial by providing a resource to address research questions, monitor care, and identify suitable subjects for clinical studies. Despite a well‐organized registry, population is often low because of the human capital required. The increasing prevalence of electronic medical health records provides the opportunity to integrate registry compilation into routine patient encounters. Here we describe how one tool existing within the Epic Medical Record software suite, Smart Phrases, can be adapted to automate population of a hearing loss patient registry. The usage rate of Smart Phrases was high and resulted in a significant reduction in the time burden associated with registry population. Use of Smart Phrases could become an important factor in the design of future registries that allow broad uptake and convenient data input.